186 results on '"Toor, Salman M."'
Search Results
2. Genome-wide association study and trans-ethnic meta-analysis identify novel susceptibility loci for type 2 diabetes mellitus
3. Contributors
4. Intrinsic and acquired cancer immunotherapy resistance
5. Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment
6. Differential gene expression of tumor-infiltrating CD33+ myeloid cells in advanced- versus early-stage colorectal cancer
7. Genome-wide association study and polygenic score assessment of insulin resistance.
8. Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancer
9. Integrated whole transcriptome and small RNA analysis revealed multiple regulatory networks in colorectal cancer
10. Identification of two HLA-A*0201 immunogenic epitopes of lactate dehydrogenase C (LDHC): potential novel targets for cancer immunotherapy
11. Immune checkpoint inhibitors: recent progress and potential biomarkers
12. Transcriptomic profiling disclosed the role of DNA methylation and histone modifications in tumor-infiltrating myeloid-derived suppressor cell subsets in colorectal cancer
13. Correction to: Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment
14. Circulating MicroRNA Profiling Identifies Distinct MicroRNA Signatures in Acute Ischemic Stroke and Transient Ischemic Attack Patients
15. The Genetic Spectrum of Maturity-Onset Diabetes of the Young (MODY) in Qatar, a Population-Based Study
16. Identification of distinct circulating microRNAs in acute ischemic stroke patients with type 2 diabetes mellitus
17. Myeloid cells in circulation and tumor microenvironment of breast cancer patients
18. The Prevalence and Genetic Spectrum of Familial Hypercholesterolemia in Qatar Based on Whole Genome Sequencing of 14,000 Subjects
19. DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancer
20. Circulating and Tumor-Infiltrating Immune Checkpoint-Expressing CD8+ Treg/T Cell Subsets and Their Associations with Disease-Free Survival in Colorectal Cancer Patients
21. T‐cell responses and therapies against SARS‐CoV‐2 infection
22. Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancer
23. Identification of two HLA-A*0201 immunogenic epitopes of lactate dehydrogenase C (LDHC): potential novel targets for cancer immunotherapy
24. The Genetic Spectrum of Maturity-Onset Diabetes of the Young (MODY) in Qatar, a Population-Based Study.
25. Circulating MicroRNA Profiling Identifies Distinct MicroRNA Signatures in Acute Ischemic Stroke and Transient Ischemic Attack Patients.
26. Chapter Fourteen - Intrinsic and acquired cancer immunotherapy resistance
27. Identification of Novel Circulating miRNAs in Patients with Acute Ischemic Stroke
28. DNA methylation in the promoters of PD-L1, MMP9, ARG1, galectin-9, TIM-3, VISTA and TGF-β genes in HLA-DR– myeloid cells, compared with HLA-DR+ antigen-presenting cells
29. Comprehensive Transcriptomic Profiling of Murine Osteoclast Differentiation Reveals Novel Differentially Expressed Genes and LncRNAs
30. Circulating and Tumor-Infiltrating Immune Checkpoint-Expressing CD8 + Treg/T Cell Subsets and Their Associations with Disease-Free Survival in Colorectal Cancer Patients.
31. Transcriptome of Tumor-Infiltrating T Cells in Colorectal Cancer Patients Uncovered a Unique Gene Signature in CD4+ T Cells Associated with Poor Disease-Specific Survival
32. Differential expression of TIM-3 in circulation and tumor microenvironment of colorectal cancer patients
33. Tumor-Infiltrating Lymphoid Cells in Colorectal Cancer Patients with Varying Disease Stages and Microsatellite Instability-High/Stable Tumors
34. Transcriptomic Profiling of Circulating HLA-DR– Myeloid Cells, Compared with HLA-DR+ Myeloid Antigen-presenting Cells
35. An evaluation of sorter induced cell stress (SICS) on peripheral blood mononuclear cells (PBMCs) after different sort conditions - Are your sorted cells getting SICS?
36. Targeting TIM-3 in solid tumors: innovations in the preclinical and translational realm and therapeutic potential
37. Epigenetic regulation of immune checkpoints and T cell exhaustion markers in tumor-infiltrating T cells of colorectal cancer patients
38. Immune checkpoints in the tumor microenvironment
39. Differential gene expression of tumor-infiltrating CD33+ myeloid cells in advanced- versus early-stage colorectal cancer
40. Transcriptomic Analyses of Myeloid-Derived Suppressor Cell Subsets in the Circulation of Colorectal Cancer Patients
41. Differential gene expression of tumor-infiltrating CD8+T cells in advanced versus early-stage colorectal cancer and identification of a gene signature of poor prognosis
42. Transcriptomic Profiling of Circulating HLA-DR– Myeloid Cells, Compared with HLA-DR+ Myeloid Antigen-presenting Cells
43. Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression
44. Editorial of Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine
45. Blockade of PD-1, PD-L1, and TIM-3 Altered Distinct Immune- and Cancer-Related Signaling Pathways in the Transcriptome of Human Breast Cancer Explants
46. Myeloid Cells in Circulation and Tumor Microenvironment of Colorectal Cancer Patients with Early and Advanced Disease Stages
47. Pembrolizumab Interferes with the Differentiation of Human FOXP3+–Induced T Regulatory Cells, but Not with FOXP3 Stability, through Activation of mTOR
48. Differential gene expression of tumor-infiltrating CD4+ T cells in advanced versus early stage colorectal cancer and identification of a gene signature of poor prognosis
49. Immune Checkpoints in Circulating and Tumor-Infiltrating CD4+ T Cell Subsets in Colorectal Cancer Patients
50. Transcriptomic Profiling of Circulating HLA-DR– Myeloid Cells, Compared with HLA-DR+ Myeloid Antigen-presenting Cells.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.